Literature DB >> 26159516

Single-Layer WEBs: Intrasaccular Flow Disrupters for Aneurysm Treatment—Feasibility Results from a European Study.

J Caroff1, C Mihalea2, J Klisch3, C Strasilla3, A Berlis4, T Patankar5, W Weber6, D Behme7, E A Jacobsen8, T Liebig9, S Prothmann10, C Cognard11, T Finkenzeller12, J Moret13, L Spelle13.   

Abstract

BACKGROUND AND
PURPOSE: The safety and efficiency of the dual-layer Woven EndoBridge (WEB) device has already been published. However, this international multicenter study sought to evaluate the safety of single-layer devices, which are the newest generation of the WEB intrasaccular flow-disrupter family. They have been designed to offer smaller-sized devices with a lower profile to optimize navigability and delivery, which may, in turn, broaden their range of use.
MATERIALS AND METHODS: Data from all consecutive patients treated with a single-layer WEB device, in 10 European centers from June 2013 to May 2014 were included. Clinical presentations, technical details, intra- and perioperative complications, and outcomes at discharge were recorded. Clinical and angiographic data at last follow-up were also analyzed when available.
RESULTS: Ninety patients with 98 WEB-treated aneurysms were included in this study. In 93 cases (95%), WEB placement was possible. Complete occlusion at the end of the procedure was obtained in 26 instances (26%). Additional treatment during the procedure (coiling and/or stent placement) was necessary in 12 cases (12.7%). Procedure-related complications occurred in 13 cases, leading to permanent neurologic deficits in 4 patients (4.4%). Early vascular imaging follow-up data were available for 44 patients (57%), with an average time interval of 3.3 months. Treatment-related morbidity and mortality rates at last follow-up were 2.2% and 1.1%, respectively.
CONCLUSIONS: In this study, the feasibility and safety of the single-layer WEB device was comparable with that of the double-layer. However, further studies are needed to evaluate long-term efficacies.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26159516      PMCID: PMC7965028          DOI: 10.3174/ajnr.A4369

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  9 in total

1.  WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study.

Authors:  B Lubicz; J Klisch; J-Y Gauvrit; I Szikora; M Leonardi; T Liebig; N P Nuzzi; E Boccardi; F D Paola; M Holtmannspötter; W Weber; E Calgliari; V Sychra; B Mine; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-23       Impact factor: 3.825

2.  WEB intrasaccular flow disruptor-prospective, multicenter experience in 83 patients with 85 aneurysms.

Authors:  C Papagiannaki; L Spelle; A-C Januel; A Benaissa; J-Y Gauvrit; V Costalat; H Desal; F Turjman; S Velasco; X Barreau; P Courtheoux; C Cognard; D Herbreteau; J Moret; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

3.  WEB device for endovascular treatment of wide-neck bifurcation aneurysms.

Authors:  B Lubicz; B Mine; L Collignon; D Brisbois; G Duckwiler; C Strother
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-04       Impact factor: 3.825

Review 4.  Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011.

Authors:  Marc Kotowski; Olivier Naggara; Tim E Darsaut; Suzanne Nolet; Guylaine Gevry; Evgueni Kouznetsov; Jean Raymond
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-25       Impact factor: 10.154

5.  Intrasaccular flow-disruption treatment of intracranial aneurysms: preliminary results of a multicenter clinical study.

Authors:  L Pierot; T Liebig; V Sychra; K Kadziolka; F Dorn; C Strasilla; C Kabbasch; J Klisch
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-07       Impact factor: 3.825

6.  Role of C-arm VasoCT in the use of endovascular WEB flow disruption in intracranial aneurysm treatment.

Authors:  J Caroff; C Mihalea; H Neki; D Ruijters; L Ikka; N Benachour; J Moret; L Spelle
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-13       Impact factor: 3.825

7.  Woven Endobridge (WEB) Device for endovascular treatment of ruptured intracranial wide-neck aneurysms: a single-center experience.

Authors:  Jildaz Caroff; Cristian Mihalea; Francesco Dargento; Hiroaki Neki; Léon Ikka; Nidhal Benachour; Jacques Moret; Laurent Spelle
Journal:  Neuroradiology       Date:  2014-06-15       Impact factor: 2.804

8.  Endovascular WEB flow disruption in middle cerebral artery aneurysms: preliminary feasibility, clinical, and anatomical results in a multicenter study.

Authors:  Laurent Pierot; Joachim Klisch; Christophe Cognard; Istvan Szikora; Benjamin Mine; Krzysztof Kadziolka; Vojtech Sychra; Istvan Gubucz; Anne-Christine Januel; Boris Lubicz
Journal:  Neurosurgery       Date:  2013-07       Impact factor: 4.654

9.  Difficult aneurysms for endovascular treatment: overwide or undertall?

Authors:  W Brinjikji; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2009-05-20       Impact factor: 3.825

  9 in total
  17 in total

1.  Two-Center Experience in the Endovascular Treatment of Intracranial Aneurysms Using the Woven EndoBridge 17 Device Including Midterm Follow-Up Results: A Retrospective Analysis.

Authors:  C Maurer; I König; A Berlis; W Weber; S Fischer
Journal:  AJNR Am J Neuroradiol       Date:  2019-09       Impact factor: 3.825

2.  Treatment of Wide-Neck Intracranial Aneurysms with the Woven EndoBridge Device Associated with Stenting: A Single-Center Experience.

Authors:  F Cagnazzo; R Ahmed; C Dargazanli; P-H Lefevre; G Gascou; I Derraz; S A Kalmanovich; C Riquelme; A Bonafe; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-11       Impact factor: 3.825

3.  A systematic review and meta-analysis of Woven EndoBridge single layer for treatment of intracranial aneurysms.

Authors:  Sbt van Rooij; M E Sprengers; J P Peluso; J Daams; D Verbaan; W J van Rooij; C B Majoie
Journal:  Interv Neuroradiol       Date:  2020-02-06       Impact factor: 1.610

4.  Occlusion assessment of intracranial aneurysms treated with the WEB device.

Authors:  Jildaz Caroff; Cristian Mihalea; Titien Tuilier; Xavier Barreau; Christophe Cognard; Hubert Desal; Laurent Pierot; Armelle Arnoux; Jacques Moret; Laurent Spelle
Journal:  Neuroradiology       Date:  2016-06-16       Impact factor: 2.804

5.  Metal coverage ratio of pipeline embolization device for treatment of unruptured aneurysms: Reality check.

Authors:  Liang-Der Jou; Gouthami Chintalapani; Michel E Mawad
Journal:  Interv Neuroradiol       Date:  2015-11-30       Impact factor: 1.610

6.  Flow-Diverter Stents for the Treatment of Saccular Middle Cerebral Artery Bifurcation Aneurysms.

Authors:  J Caroff; H Neki; C Mihalea; F D'Argento; H Abdel Khalek; L Ikka; J Moret; L Spelle
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

7.  Woven Endobridge (WEB) device for endovascular treatment of complex unruptured aneurysms-a single center experience.

Authors:  Stephanie Lescher; Richard du Mesnil de Rochemont; Joachim Berkefeld
Journal:  Neuroradiology       Date:  2016-01-15       Impact factor: 2.804

8.  Experimental testing of the dual-layer Woven EndoBridge device using an elastase-induced aneurysm model in rabbits.

Authors:  Yong-Hong Ding; Daying Dai; Dana Schroeder; Ramanathan Kadirvel; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-02-03       Impact factor: 1.610

9.  Delayed rebleeding of an Acom aneurysm treated with a web device: Endovascular management.

Authors:  Benjamin Mine; Thomas Bonnet; Adrien Guenego; Stéphanie Elens; Juan V Suarez; Boris Lubicz
Journal:  Interv Neuroradiol       Date:  2021-04-20       Impact factor: 1.610

10.  WEB Device Shape Changes in Elastase-Induced Aneurysms in Rabbits.

Authors:  Y Ding; D Dai; A Rouchaud; K Janot; S Asnafi; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.